NCT06608342View on ClinicalTrials.gov

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2028

Conditions
Acute Lymphoblastic Leukemia ALL
Interventions
BIOLOGICAL

Autologous hematopoietic stem cell transplantation combined with CD19-CART

Autologous CD19-CAR T cells were transfused +7 days after autologous hematopoietic stem cell transplantation

Trial Locations (1)

300000

RECRUITING

NO.288 Nanjing Road，Heping District，Tianjin, Tianjin,, Tianjin

Sponsors
All Listed Sponsors
collaborator

Juventas Cell Therapy Ltd.

INDUSTRY

lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER